Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Cephradine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Centrient Pharmaceuticals
    Netherlands
    		 CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL R1-CEP 2005-181 - Rev 03 Cefradine, Enzymatic process 2019-09-09 Valid Chemical 814
    28/10/2024 Orchid Pharma
    India
    		 ORCHID PHARMA LIMITED Alathur IN CEP 2002-231 - Rev 04 Cefradine 2024-09-06 Valid Chemical 814